Nureca Limited

NSE:NURECA.NS

240.11 (INR) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Revenue 341.76317.4264.63311.89202.69169.7223.74313.53212.31212.26277.88367.81255.28410.49480.77469.41,194.82318.4594.69919.28302.17329.6
Cost of Revenue 221.78189.71165.31245.24164.55111.81158.79191.34144.21176.72167.13274.16170.81258.79292.53280.49494.43164.48328.34382.1696.78224.04
Gross Profit 119.98127.6999.3266.6538.1457.8964.95122.1968.135.54110.7593.6584.47151.7188.24188.91700.39153.92266.35537.12205.39105.56
Gross Profit Ratio 0.3510.4020.3750.2140.1880.3410.290.390.3210.1670.3990.2550.3310.370.3920.4020.5860.4830.4480.5840.680.32
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 00000-9.5900039.7300037.1700041.8818.5356.315.370
Selling & Marketing Expenses 0000040.2700035.98000117.3800047.9447.9417.62.530
SG&A 042.7096.4268.3930.680069.2475.71092.70154.550105.66204.3189.8266.47523.917.98.57
Other Expenses 130.9178.21144.8600103.58113.41122.1900110.75084.470188.2426.0326.7-14.498.6056.641.640
Operating Expenses 130.91120.91144.8696.4268.39103.58113.41122.1968.174.12110.7592.784.47151.7188.24131.69231.01153.92165.08176.0976.468.57
Operating Income -10.936.78-45.54-29.77-30.25-45.69-48.4691.54-34.86-37.37-15.17-55.27-63.36-25.5246.9757.22469.3853.95101.27368.19128.9735.65
Operating Income Ratio -0.0320.021-0.172-0.095-0.149-0.269-0.2170.292-0.164-0.176-0.055-0.15-0.248-0.0620.0980.1220.3930.1690.170.4010.4270.108
Total Other Income Expenses Net 23.2413.7313.0229.0256.44-19.0357.91-52.4225.5717.6417.8717.8810.366.4716.2319.8619.2-1.96-16.38-8.74-1.97-3.37
Income Before Tax 12.3120.51-32.52-0.7526.19-64.729.4539.12-9.29-19.732.7-37.39-53-19.0563.277.08488.5851.9984.89359.4512732.28
Income Before Tax Ratio 0.0360.065-0.123-0.0020.129-0.3810.0420.125-0.044-0.0930.01-0.102-0.208-0.0460.1310.1640.4090.1630.1430.3910.420.098
Income Tax Expense 4.18-4.16-4.514.079.57-23.267.810.18-2.22-4.43-0.31-8.47-11.71-5.1115.8622.74126.6213.0821.8692.1232.538.46
Net Income 8.1324.67-28.01-4.8216.62-41.461.6528.94-7.07-15.33.01-28.92-41.29-14.0447.3454.34361.9638.9163.03267.3394.4723.82
Net Income Ratio 0.0240.078-0.106-0.0150.082-0.2440.0070.092-0.033-0.0720.011-0.079-0.162-0.0340.0980.1160.3030.1220.1060.2910.3130.072
EPS 0.812.47-2.8-0.481.66-4.150.162.9-0.71-1.530.3-2.89-4.13-1.394.735.4336.24.568.5136.0913.53.4
EPS Diluted 0.812.47-2.8-0.481.66-4.150.162.9-0.71-1.530.3-2.89-4.13-1.394.735.4336.24.568.5136.0913.53.4
EBITDA 20.1131.93-25.378.1434.25-56.9316.4645.84-2.3-13.089.8-30.18-45.58-10.2868.5681.44492.3255.2487.03368.53131.5335.843
EBITDA Ratio 0.0590.101-0.0960.0260.169-0.3350.0740.146-0.011-0.0620.035-0.082-0.179-0.0250.1430.1730.4120.1730.1460.4010.4350.109